Corneal collagen cross-linking for Terrien marginal degeneration.
J Refract Surg
; 30(7): 498-500, 2014 Jul.
Article
em En
| MEDLINE
| ID: mdl-24892378
ABSTRACT
PURPOSE:
To report the long-term clinical outcome of a patient diagnosed as having Terrien marginal degeneration (TMD) who was subjected to corneal collagen cross-linking (CXL) with ultraviolet-A and riboflavin in both eyes.METHODS:
Topographical changes were assessed by high-resolution Scheimpflug imaging and anterior segment optical coherence tomography. Eccentric epithelium-off CXL was performed in both eyes while protecting the corneal limbus. Irradiation was performed with a fluence of 5.4 J/cm(2), using 3 mW/cm(2) for 30 minutes.RESULTS:
Five years of postoperative follow-up showed regression of the keratometric values, a local thickening of the corneal stroma, and bilateral improvement of corrected distance visual acuity.CONCLUSIONS:
CXL may arrest progression in TMD and even reverse the catabolic process in the corneal stroma. CXL might represent an alternative therapeutic approach for the management of TMD.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Riboflavina
/
Distrofias Hereditárias da Córnea
/
Colágeno
/
Fármacos Fotossensibilizantes
/
Substância Própria
/
Reagentes de Ligações Cruzadas
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article